Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting: A Randomized Multicenter Trial
Matteo Tebaldi, C. Tumscitz, Marco Borghesi, Marco Valgimigli
Circulation, 2012
View PDFchevron_right
Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long‐Term Outcomes
Lien Quach
Journal of the American Heart Association, 2021
View PDFchevron_right
Causes of late mortality with dual antiplatelet therapy after coronary stents
Dean Kereiakes
European heart journal, 2015
View PDFchevron_right
Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study
Javad Kojuri
Medicine, 2016
View PDFchevron_right
Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)
Edouard Benit
EuroIntervention, 2019
View PDFchevron_right
Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study
Dean Kereiakes
JAMA cardiology, 2017
View PDFchevron_right
Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials
Giuseppe Ferrante
Circulation. Cardiovascular interventions, 2017
View PDFchevron_right
Discontinuation of Dual Antiplatelet Therapy Over 12 Months after Acute Coronary Syndromes Increases Risk for Adverse Events in Patients Treated with Percutaneous Coronary Intervention: Systematic Review and Meta-Analysis
Matthew Reed
Journal of Interventional Cardiology, 2014
View PDFchevron_right
Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a consensus?
Francesco Costa, Sara Ariotti
European Heart Journal, 2015
View PDFchevron_right
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
Francesco Costa
BMJ (Clinical research ed.), 2015
View PDFchevron_right
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and America...
Peter Lockhart
Catheterization and Cardiovascular Interventions, 2007
View PDFchevron_right
Dual antiplatelet platelet therapy duration following coronary stenting
Dean Kereiakes
Journal of the American College of Cardiology, 2015
View PDFchevron_right
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial
John Ormiston
JAMA, 2015
View PDFchevron_right
Individualization of dual antiplatelet therapy duration after drug-eluting stent implantation: paradigm and reality
Adnan Kastrati
European Heart Journal, 2013
View PDFchevron_right
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperp...
Matteo Tebaldi
JACC. Cardiovascular interventions, 2014
View PDFchevron_right
Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial
monica masotti
Journal of the American College of Cardiology
View PDFchevron_right
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Ioannis Mastoris, samantha sartori
Journal of the American College of Cardiology, 2015
View PDFchevron_right
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
Ioannis Mastoris, Gennaro Giustino
Journal of the American College of Cardiology, 2015
View PDFchevron_right
Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation
seyed fazel Hosseini
The Journal of Tehran University Heart Center, 2012
View PDFchevron_right
Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy
Corrado Lettieri
The American Journal of Cardiology, 2008
View PDFchevron_right
Short versus prolonged dual antiplatelet therapy duration after bare-metal stent implantation: 2-month landmark analysis from the CREDO-Kyoto registry cohort-2
toshiaki toyota
Cardiovascular Intervention and Therapeutics, 2016
View PDFchevron_right
Efficacy and safety of short-term (≤6 months) duration of dual antiplatelet therapy after drug-eluting stents: a meta-analysis of randomized controlled trials
LONG ZENG
Anatolian journal of cardiology, 2016
View PDFchevron_right
Duration of dual antiplatelet therapy after coronary artery stenting: where is the sweet spot between ischaemia and bleeding?
Angeliki Papapanagiotou
European heart journal, 2015
View PDFchevron_right
Optimal Duration of Antiplatelet Therapy in Recipients of Coronary Drug-Eluting Stents
Giulia Renda
Drugs, 2005
View PDFchevron_right
Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Randomized, Controlled Trial
Elsayed Abo-salem
Circulation, 2014
View PDFchevron_right
Long-Term Predictors of Mortality After Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents
Martin Sebastian
The American Journal of Cardiology, 2011
View PDFchevron_right
A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary LesionsResults From the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduce...
Soo-jin Kang
Journal of the American College of Cardiology, 2011
View PDFchevron_right
Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES Study
Bernhard Witzenbichler
Circulation. Cardiovascular interventions, 2015
View PDFchevron_right
Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS
Pavel Červinka, Josef Veselka
Catheterization and Cardiovascular Interventions, 2009
View PDFchevron_right
TCT-18 Clinical and Procedural Predictors and Consequences of Stent Thrombosis Following Drug-eluting Stents for Acute Coronary Syndromes: Results From the ADAPT-DES Study
Ankit Garg
Journal of the American College of Cardiology, 2013
View PDFchevron_right
Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome
Peter Den Heijer
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2017
View PDFchevron_right
Short- Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
Philippe Généreux
Journal of the American College of Cardiology, 2015
View PDFchevron_right
Long-Term Efficacy and Safety Outcomes After Unrestricted Use of Drug-Eluting Stents in Patients With Acute Coronary Syndrome
Naritatsu Saito
Circulation Journal, 2014
View PDFchevron_right